|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/00 | |||
| A61P 35/04 | |||
| A61P 35/00 |
| (11) | Number of the document | 3044235 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14761904.3 |
| Date of filing the European patent application | 2014-09-11 | |
| (97) | Date of publication of the European application | 2016-07-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/069451 |
| Date | 2014-09-11 |
| (87) | Number | WO 2015/036511 |
| Date | 2015-03-19 |
| (30) | Number | Date | Country code |
| 13184120 | 2013-09-12 | EP |
| (72) |
HERTING, Frank, DE
RIES, Carola, DE
WARTHA, Katharina, DE
HOVES, Sabine, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND ANTIBODIES AGAINST HUMAN PD-L1 |
| COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND ANTIBODIES AGAINST HUMAN PD-L1 |